Home / MATCAP2 Knockout Cell Lines

MATCAP2 Knockout Cell Lines

Gene: MATCAP2

Official Full Name: microtubule associated tyrosine carboxypeptidase 2provided by HGNC

Gene Summary: Predicted to enable carboxypeptidase activity; metal ion binding activity; and metallopeptidase activity. Predicted to be involved in proteolysis. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO16317 MATCAP2 Knockout cell line (HeLa) Human MATCAP2 1:3~1:6 Negative Online Inquiry
KO16318 MATCAP2 Knockout cell line (HCT 116) Human MATCAP2 1:2~1:4 Negative Online Inquiry
KO16319 MATCAP2 Knockout cell line (HEK293) Human MATCAP2 1:3~1:6 Negative Online Inquiry
KO16320 MATCAP2 Knockout cell line (A549) Human MATCAP2 1:3~1:4 Negative Online Inquiry

Background

MATCAP2 Gene Knockout Cell Lines are specifically engineered cellular models that lack the expression of the MATCAP2 gene, a critical component involved in multiple biological processes, including cellular adhesion and signaling pathways. These cell lines are created through advanced CRISPR-Cas9 technology, ensuring precise and reliable gene deletion that allows researchers to study the effects of MATCAP2 deficiency on cellular behavior and phenotype.

The primary function of MATCAP2 Gene Knockout Cell Lines is to enable in-depth investigation into the role of MATCAP2 in various biological systems, particularly in the context of disease models such as cancer, metabolic disorders, and developmental biology. By eliminating MATCAP2 expression, these cell lines facilitate the study of altered signaling cascades, changes in cell morphology, and variations in responsiveness to therapeutic agents. This model is pivotal for elucidating the pathological mechanisms driven by MATCAP2 and for identifying potential therapeutic targets.

The scientific importance of MATCAP2 Gene Knockout Cell Lines extends to both research and clinical applications. They serve as vital tools for basic science investigations, preclinical drug testing, and the validation of novel therapeutic strategies. Researchers can utilize these models to bridge the gap between molecular biology and clinical application, potentially leading to innovative treatment approaches in disorders linked to aberrant MATCAP2 function.

Compared to alternative models, MATCAP2 Gene Knockout Cell Lines boast enhanced specificity, as they offer a more accurate representation of MATCAP2 deficiency than transient knockdown systems, which may produce heterogeneous results. Furthermore, they enable longitudinal studies due to their stable genetic modification, delivering consistent and reproducible data over time.

For researchers and clinicians, the value of MATCAP2 Gene Knockout Cell Lines lies in their ability to provide insights into fundamental biological questions and therapeutic interventions. By utilizing these cell lines, users can significantly accelerate their research, enabling them to generate critical data that can lead to the advancement of knowledge in related fields.

Our company specializes in the development of innovative biological tools, such as MATCAP2 Gene Knockout Cell Lines, leveraging cutting-edge genetic engineering techniques to support researchers in their pursuit of scientific discovery. With a commitment to quality and reliability, we are dedicated to equipping our customers with the resources necessary to drive impactful research forward.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.